Jan.09
5:52 PM ET
Monday, 9 Jan 2012
As the JPMorgan Health Care conference kicks off this week, one question remains for investors in the biotech space. What’s the next takeover target as large drug makers look to build out their pipeline? Read More
Sectors:Biotechnology | Health Care | Pharmaceuticals
VIDEO | COMPANIES : Emergent Biosolutions, Inc.
Andrew Freris, Chief Investment Advisor for Asia, BNP Paribas Wealth Management, says China has managed to get the econo...
Emerging markets turn negative for the year. Could the U.S. selloff be mirroring the dip in the emerging markets? Tim Se...
Tim Seymour, Triogem Asset Management, discusses the continuing struggle in emerging markets and the best way to trade m...
With Europe imploding and the U.S. markets teetering, Ruchir Sharma, Morgan Stanley, offers insight on three emerging ma...
Discussing opportunities in emerging markets now, Chesapeake Energy and NRG's shift from nuclear to solar and natural ga...
More Videos
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2012 CNBC LLC. All Rights Reserved.
